Drug application
ERIBULIN MESYLATE (ERIBULIN MESYLATE)
Drugs@FDA ANDA 218047 · GLAND
Key facts
| Drug name | ERIBULIN MESYLATE |
|---|---|
| Active ingredients | ERIBULIN MESYLATE |
| Application type | ANDA |
| Application number | 218047 |
| Company | GLAND |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 1MG/2ML (0.5MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Apr 5, 2024 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: